A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease
Molecular Genetics & Genomic Medicine · 2023
DOI: 10.1002/mgg3.2217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, 2023. Verfasst von Qianying Zhao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Genetics, West China Second University Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Alternative Splicing, Polycystic Kidney, Autosomal Dominant, TRPP Cation Channels. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Autosomal dominant polycystic kidney disease (ADPKD) is mainly caused by pathogenic variants of PKD1 and PKD2 . Compared to PKD2 ‐related patients, patients with PKD1 pathogenic variants have more severe symptoms, present a gradual decline in renal function, and finally progress to end‐stage kidney disease with an earlier mean onset age.
Methods
In this study, trio exome sequencing (ES) was performed to reveal the genetic etiology in a Chinese family clinically diagnosed with polycystic kidney, followed by validation through Sanger sequencing on both genomic DNA and cDNA levels. Subsequently, targeted preimplantation genetic testing was provided for the family.
Results
A novel heterozygous PKD1 variant (c.1717_1722+11del) was detected in the proband and other clinically‐affected relatives. Interestingly, cDNA sequencing demonstrated that the variant, despite being annotated as non‐frameshift within exon 8, impacted the splicing of PKD1 . Two abnormal transcription products were formed: one induced frameshift, while the other caused 133 amino acids to be inserted between exon 8 and exon 9.
Conclusions
Our study revealed a novel PKD1 variant using ES as the cause of ADPKD in a Chinese family with multiple affected members. The variant at the exon‐intron boundary would induce alternative splicing, which should not be excluded from genetic analysis. Validated on the cDNA level could provide more comprehensive genetic information for disease stratification. And the novel variant expands the spectrum of PKD1 variants in ADPKD. The recurrent risk could be blocked accordingly for the families' offspring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Genetics, West China Second University Hospital, Sichuan University, Chengdu, China.
- Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, Chengdu, China.
ORCID-Profile: Qianying Zhao, Yu Tan, Mei Yang
Zitieren
APA
Zhao, Q., Tan, Y., Xiao, X., Xiang, Q., Yang, M., Wang, H., & Liu, S. (2023). A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease. Molecular Genetics & Genomic Medicine. https://doi.org/10.1002/mgg3.2217
Vancouver
Zhao Q, Tan Y, Xiao X, Xiang Q, Yang M, Wang H, et al. A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease. Molecular Genetics & Genomic Medicine. 2023. doi:10.1002/mgg3.2217
BibTeX
@article{Zhao2023,
author = {Zhao, Qianying and Tan, Yu and Xiao, Xiao and Xiang, Qinqin and Yang, Mei and Wang, He and Liu, Shanling},
title = {A novel heterozygous PKD1 variant causing alternative splicing in a Chinese family with autosomal dominant polycystic kidney disease},
journal = {Molecular Genetics & Genomic Medicine},
year = {2023},
doi = {10.1002/mgg3.2217}
}
EUVIMED